re :big chomp, page-5

Klaas has valued TZ post float $3-5 subject to expected takeup of new licenses we have been hearing about. Obviously it depends on all sorts of events whose outcomes are yet to be resolved. I remain confident the intrinsic valuations post recent and expected short term M&A activity and immediately commensurate with the NASDAQ listing place TZ around $2.25-2.50. This would place a value of US$300M on TZ at listing, a figure I expect to be underwritten.

I will keep the stock because, like Klaas, I believe the applications are so widespread that the future growth is likely to result in a further doubling of the sp. Perhaps there are many here who are heavily committed to TZ as a proportion of their total holding and as such are less patient. That lack of patience driven by economic pressures is not a good feeling so I avoid it where possible. It stops me making distorted decisions, like selling early.